will employees quarter, industry on benefit the strides in growth Thank made near-term cannabis our continue for you, initiatives, long-term. and the consumers. Anna, capitalize both the the second shareholders, strengthen of key we in and Cronos on us opportunities and In everyone. partners, the foundation global which success and morning, to significant Group’s for good help We
through Winnipeg, call, into more in a have capabilities and market by and CBD and acquired XX the Officer we product GMP last announced concentrate entrance But of derivative platform, chain go experience, our manufacturing our compliant shortly. a facility years of a with details our continued over co-manufacturing leading hired Chief fermentation our for into state-of-the-art U.S. cannabis CPG I’ll expansion third-party launch. supply since Innovation these hemp-derived each on securing
who those aspects with start Cronos’ Cronos our by Group, strategy. briefly to four call each I be the story like listening, reviewing For supply of an global establishing we unfamiliar chain. may key At efficient are
diversified sales distribution We global a are network. developing and
a products And are and consumers. creating are growing portfolio with that disruptive We a intellectual property. of ionic resonate we brands
we terminology going global first describe our that notice strategy. global to may new And production refer forward, we to footprint will use the You of as our pillar chain. supply
often discussed have not our is mature We of end, the the in driver an a value. capacity key view means to market, that
modeling investors Now, are companies off we understand cannabis that capacity. production their of many
other there verticals not farmer. but that and value verticals. branded the many will to across the all we innovative partnering rather where think long-term our created we we the will cannabis areas on and business We in be sustainable model focus However, things is people, marketing tremendous opportunity, experts with while value research recognize can’t like and industry products we all development be be see see in
value the the This best packaged contract We by chain capacity consumer And will is to as to pharmaceuticals. farmers needs. analogous working we successful focused proven supply well. to and successful our prove believe that think industries, approach with the firmly is goods suppliers in in it industry and such way support cannabis create as
partners company’s ventures with asset-light meet first-class has cultivation co-manufacturing our chain with order We and demands. future of global Cronos to network up supply approach Group in set by the creating have for operating growth a structured a joint
supply-chain products to supplement of the Canada, the efficiencies. excited which of We new and cannabis and But secured drive support concentrate in this and recently also third-party with own work launch as we’re products to will into cannabis agreements supply comes derivative cannabis-derived co-manufacturing Canadian producers production supply online, fall. later services our market
suppliers formulations and products brands. for our the by Group proprietary unique developed These third-party co-manufacturing of co-packers and Cronos utilize and will different
we As the a contractors plan to to high-quality industry us and continue develops third-party specialized provide and to matures, engage services inputs.
Naturals As cultivation strategy similar Cronos going Australia transitioning holdings. the of does is sale a Australian to evolves our taking Australia obtaining medical products process by necessary importing progresses, so a import some permits. and that in of all from approach is be range Cronos scalable our at Peace the of market. for to
a our supply to companies. continue in facility which pharmaceutical Canada’s acquired generic Apotex, largest from compliant As fermentation chain, have of GMP is we diversify state-of-the-art we Canada and manufacturing one
Fermentation chemistry, microbial fully-equipped two production organic laboratories as microbiology, and Cronos as and analytical control method well fermentation quality development includes covering areas. large-scale
they already are expect fourth While and finish certain activities. manufacturing there down applicable the licenses to team the applying transaction for has while in the closed, we winding currently Apotex talented quarter, hire
September, [ph] [advanced] need the on cultured Gingko expected facility landmark is cannabinoids commercial at that focused we and provide Bioworks. manufacturing our capitalize launched partnership producing with on R&D This underway scale. we Last Gingko, fermentation capabilities to progress the to with
not bringing Together industry. R&D potential large This produce that for Cannabis the CBD, and believe at traditional Gingko and the allow purity to Gingko, We scale partnership disrupt cultivation. cannabinoid high cultivation efficient but to power landmark to through with only our has current rare biological the of to THC are to impractical also at economically we are with is or traditional compared and scale which production innovation extraction model. the includes cannabinoids expected and near-impossible the industry, manufacturing
industry-disruptive progress scale our and to rollout. to Cronos by of will in initiative us that the feel with a advance manufacturing that Fermentation accelerate potentially be allow fermentation commercial pleased this in progress we continue We cannabinoid optimizing process
will overseeing focus industries. and on Officer. Gingko new initiatives, a is IP we of research Chief practices last play Abraham and Abraham and facet adopting important from role Group’s expanding the disruptive will our Dr. pleasure in Todd identifying an appointing And Cronos development month innovations had portfolio. technologies to key best Dr. as Innovation and our adjacent
positions goods consumer veteran, as worked extensive and having global from and consumer & identifying, senior in such Abraham goods. is Gamble. experience commercializing Procter Group breakthrough technology companies Cronos industry for in a to Mondelez, Pillsbury developing Dr. brings He leading
I growth strategic cannabinoid believe development, business leader experience Todd’s organizational in strategy coupled skills a his nutritional with science, own R&D, global innovation. accelerate and our in will as
in category that we will food developing in be be Cronos, category. and and products believe Todd’s long launching of At success an to driving record the of functional edibles track important key and term, a range attractive will successfully that our
Cronos impressive is facility Cronos R&D our focused accelerate an development we of also the of device launched Device supporting to next-generation quarter technology. products. on Labs, development vaporizer This Device Labs
of remains with is space with consumers that specifically in the evolving migrating fastest infancy growing vaporizer same many are the time, and this its for convenient, to the the categories, At know We few method. category non-combustible one tailored consumption products cannabinoids.
cannabinoids us These into products are controlled launch technology is less initiative enhance developed consistent in This in delivering the and our significantly expected a even our and in to category. manner. will support upcoming vaporizer capabilities, and development
which into allow Canadian vaporizer the consumers to this expand market. in the we later regulations, continue will are cannabis Canada the excited category year. distribution for in products, will we Canadian our derivative in footprint With As be can upcoming launching we changes evolve, products offer to
we consumer data for natural to for capabilities we Cronos the offer from look created with this products derivative regulations Labs, in as Canada, category combined insight that with have for this our us, Device methods a launch in choice a and additional The consumption in U.S. our products. Canadians makes space
priority. across products to Canada, quality designed to top responsibly most We’re the importantly, which our vape safety looking and ensuring have demand, forward and meet launching been consumer are
Group market a week, announce leading Cronos have hemp-derived We the manufactures, into for four based hospitality distributes Jones online in that hemp-derived operating agreed $XXX U.S. subsidiaries, and channels retail are to equally million. the announced CBD Last products. under partner and consumer Redwood CBD through infused LA entrance other through and Redwood excited are sold brand. These skincare a acquire we premium approximately products to Lord our and platform. markets Holding
Redwood developed of consistency. quality and launch to by brand. built Capobianco, in platform who CBD future pipeline of differentiated that scale hemp-based Cindy brands co-founded have hope and products was and in have formulations along Lord with best-in-class for the stand we Rob Jones They the Rosenheck a that the
transaction, of would with the Cronos close names. continue the the development current it the brand and lead Redwood join the Following team the and to support Group platform of of
and in the learning has Cindy signification of to resources is also skin and from leveraging consumer capitalize hemp. products while preserve created, derived the goal other care and from that demand all Our Cronos’s for Rob integrity them
the with strategic at hemp-derived our We’re excited market to looking partner the be assistance Altria. of U.S.
globally. our the right have grow Altria’s previously our investment as push partner As we forward we and corner, ensures announced, strategic in business
already manufacturing, brand and expertise distribution opportunity. U.S. developed Altria’s in engineering, building plan Altria product the leverage that support and tapping hemp-derived capabilities of We’re in has innovation to and
for by we’re responsibility, We the believe that business. success investing ultimately in our innovation and long-term in positioning and company
long-term on continue and resonate believe sustainable are we and with generate growth focused to is we strategy value. long-term will will Our that consumers building shareholder
discussion I��ll quarter’s to financial With to provide it a this Jerry on results. that, turn over
